Extracorporeal Membrane Oxygenation for Group B Streptococcal Sepsis in Neonates: A Retrospective Study of the Extracorporeal Life Support Organization Registry.
Journal
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
14
3
2020
medline:
7
1
2021
entrez:
14
3
2020
Statut:
ppublish
Résumé
Neonatal group B streptococcal sepsis remains a leading cause of neonatal sepsis globally and is characterized by unique epidemiologic features. Extracorporeal membrane oxygenation has been recommended for neonatal septic shock refractory to conventional management, but data on extracorporeal membrane oxygenation in group B streptococcal sepsis are scarce. We aimed to assess outcomes of extracorporeal membrane oxygenation in neonates with group B streptococcal sepsis. Retrospective study of the international registry of the Extracorporeal Life Support Organization. Extracorporeal membrane oxygenation centers contributing to Extracorporeal Life Support Organization registry. Patients less than or equal to 30 days treated with extracorporeal membrane oxygenation and a diagnostic code of group B streptococcal sepsis between January 1, 2007, and December 31, 2016. None. In-hospital mortality was the primary outcome. Univariable and multivariable logistic regression models to predict mortality were established. One hundred ninety-two runs in 191 neonates were identified meeting eligibility criteria, of which 55 of 191 (29%) died. One hundred thirty-seven (71%) were treated with venoarterial extracorporeal membrane oxygenation. One hundred sixty-nine runs (88%) occurred during the first week of life for early-onset sepsis and 23 (12%) after 7 days of life. The in-hospital mortality for extracorporeal membrane oxygenation used after 7 days of life was significantly higher compared with early-onset sepsis (65% vs 24%; p < 0.01). In addition, lower weight, lower pH, lower bicarbonate, and surfactant administration precannulation were significantly associated with mortality (p < 0.05). Adjusted analyses confirmed that age greater than 7 days, lower weight, and lower pH were associated with higher mortality (p < 0.05). One hundred fifty-one of 192 runs (79%) experienced a major complication. The number of major complications during extracorporeal membrane oxygenation was associated significantly with mortality (p < 0.001; adjusted odds ratio, 1.27 [1.08-1.49; p = 0.004]). This large registry-based study indicates that treatment with extracorporeal membrane oxygenation for neonatal group B streptococcal sepsis is associated with survival in the majority of patients. Future quality improvement interventions should aim to reduce the burden of major extracorporeal membrane oxygenation-associated complications which affected four out of five neonatal group B streptococcal sepsis extracorporeal membrane oxygenation patients.
Identifiants
pubmed: 32168303
doi: 10.1097/PCC.0000000000002320
pii: 00130478-202008000-00026
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e505-e512Références
Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011; 30:937–941
Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Lancet 2012; 379:547–556
Stoll BJ, Hansen NI, Sánchez PJ, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Early onset neonatal sepsis: The burden of group B streptococcal and E. coli disease continues. Pediatrics 2011; 127:817–826
Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003; 3:201–213
Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC): Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1–36
Jordan HT, Farley MM, Craig A, et al.; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC: Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: A multistate, population-based analysis. Pediatr Infect Dis J 2008; 27:1057–1064
Schlapbach LJ, Aebischer M, Adams M, et al.; Swiss Neonatal Network and Follow-Up Group: Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 2011; 128:e348–e357
Giannoni E, Berger C, Stocker M, et al.; Swiss Pediatric Sepsis Study Group: Incidence and outcome of group b streptococcal sepsis in infants in Switzerland. Pediatr Infect Dis J 2016; 35:222–224
Bekker V, Bijlsma MW, van de Beek D, et al. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: A nationwide surveillance study. Lancet Infect Dis 2014; 14:1083–1089
Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369:840–851
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138–150
MacLaren G, Butt W, Best D, et al. Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med 2011; 12:133–136
Horton S, d’Udekem Y, Shann F, et al. Extracorporeal membrane oxygenation via sternotomy for circulatory shock. J Thorac Cardiovasc Surg 2010; 139:e12–e13
Maclaren G, Butt W, Best D, et al. Extracorporeal membrane oxygenation for refractory septic shock in children: One institution’s experience. Pediatr Crit Care Med 2007; 8:447–451
Fortenberry JD, Paden ML. Extracorporeal therapies in the treatment of sepsis: Experience and promise. Semin Pediatr Infect Dis 2006; 17:72–79
MacLaren G, Pellegrino V, Butt W, et al. Successful use of ECMO in adults with life-threatening infections. Anaesth Intensive Care 2004; 32:707–710
Lin YC, Ma JY, Yeh SJ, et al. Use of extracorporeal membrane oxygenation to rescue a newborn with early-onset group B streptococcal sepsis and cardiopulmonary failure. J Formos Med Assoc 2004; 103:67–70
Luyt DK, Pridgeon J, Brown J, et al. Extracorporeal life support for children with meningococcal septicaemia. Acta Paediatr 2004; 93:1608–1611
Goldman AP, Kerr SJ, Butt W, et al. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349:466–469
Beca J, Butt W. Extracorporeal membrane oxygenation for refractory septic shock in children. Pediatrics 1994; 93:726–729
Hocker JR, Simpson PM, Rabalais GP, et al. Extracorporeal membrane oxygenation and early-onset group B streptococcal sepsis. Pediatrics 1992; 89:1–4
McCune S, Short BL, Miller MK, et al. Extracorporeal membrane oxygenation therapy in neonates with septic shock. J Pediatr Surg 1990; 25:479–482
Dellinger RP, Levy MM, Rhodes A, et al.; Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup: Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med 2013; 39:165–228
Agyeman PKA, Schlapbach LJ, Giannoni E, et al.; Swiss Pediatric Sepsis Study: Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: A population-based cohort study. Lancet Child Adolesc Health 2017; 1:124–133
Paden ML, Rycus PT, Thiagarajan RR; ELSO Registry: Update and outcomes in extracorporeal life support. Semin Perinatol 2014; 38:65–70
Barbaro RP, Paden ML, Guner YS, et al.; ELSO Member Centers: Pediatric Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J 2017; 63:456–463
Prodhan P, Bhutta AT, Gossett JM, et al. Extracorporeal membrane oxygenation support among children with adenovirus infection: A review of the Extracorporeal Life Support Organization registry. ASAIO J 2014; 60:49–56
Madrid L, Seale AC, Kohli-Lynch M, et al.; Infant GBS Disease Investigator Group: Infant group B streptococcal disease incidence and serotypes worldwide: Systematic review and meta-analyses. Clin Infect Dis 2017; 65:S160–S172
Davis AL, Carcillo JA, Aneja RK, et al. American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2017; 45:1061–1093
Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev 2015; (3):CD001239
Oberender F, Ganeshalingham A, Fortenberry JD, et al. Venoarterial extracorporeal membrane oxygenation versus conventional therapy in severe pediatric septic shock. Pediatr Crit Care Med 2018; 19:965–972
Ruth A, McCracken CE, Fortenberry JD, et al. Extracorporeal therapies in pediatric severe sepsis: Findings from the pediatric health-care information system. Crit Care 2015; 19:397
Schlapbach LJ, Chiletti R, Straney L, et al. Defining benefit threshold for extracorporeal membrane oxygenation in children with sepsis – A binational multicenter cohort study. Crit Care 2019; 23:429
Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet 2017; 390:1770–1780
Schlapbach LJ, Mattmann M, Thiel S, et al. Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis 2010; 51:153–162
Smith S, Butt W, Best D, et al. Long-term survival after extracorporeal life support in children with neutropenic sepsis. Intensive Care Med 2016; 42:942–943
Schlapbach LJ, Straney L, Alexander J, et al.; ANZICS Paediatric Study Group: Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: A multicentre retrospective cohort study. Lancet Infect Dis 2015; 15:46–54
Schmidt M, Bailey M, Sheldrake J, et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med 2014; 189:1374–1382
Giannoni E, Agyeman PKA, Stocker M, et al.; Swiss Pediatric Sepsis Study: Neonatal sepsis of early onset, and hospital-acquired and community-acquired late onset: A prospective population-based cohort study. J Pediatr 2018; 201:106.e4–114.e4
Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics 2016; 138:e20162013
Cashen K, Reeder R, Dalton HJ, et al. Acquired infection during neonatal and pediatric extracorporeal membrane oxygenation. Perfusion 2018; 33:472–482
Dalton HJ, Reeder R, Garcia-Filion P, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network: Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation. Am J Respir Crit Care Med 2017; 196:762–771
Morin L, Ray S, Wilson C, et al.; ESPNIC Refractory Septic Shock Definition Taskforce the Infection Systemic Inflammation Sepsis section of ESPNIC: Refractory septic shock in children: A European Society of Paediatric and Neonatal Intensive Care definition. Intensive Care Med 2016; 42:1948–1957
Schlapbach LJ, MacLaren G, Festa M, et al.; Australian & New Zealand Intensive Care Society (ANZICS) Centre for Outcomes & Resource Evaluation (CORE) and Australian & New Zealand Intensive Care Society (ANZICS) Paediatric Study Group: Prediction of pediatric sepsis mortality within 1 h of intensive care admission. Intensive Care Med 2017; 43:1085–1096